Mental Health and Healthcare in Adults With Intellectual Disabilities

Sponsor
Norwegian University of Science and Technology (Other)
Overall Status
Completed
CT.gov ID
NCT05703503
Collaborator
The Dam Foundation (Other), University of Tromso (Other), University Hospital of North Norway (Other), The Norwegian Association for Persons with Developmental Disabilities (Other)
214
1
26
8.2

Study Details

Study Description

Brief Summary

Intellectual disability (ID) is a diagnosis characterized by significant limitations both in intellectual functioning and in adaptive behavior as expressed in conceptual, social and practical adaptive skills. The disability originates before age 18 years. The prevalence of mental ill-health among adults with intellectual disabilities is higher than the general population. Individuals with ID use psychotropic medication extensively, but studies indicate that less than one out of three who use psychotropic drugs have a psychiatric diagnosis. The drugs are usually prescribed by a regular general practitioner. People with IDs will often require health- and social services throughout their lifetimes. Studies report worse mental and physical health among people with IDs compared to the general population, in addition to more unmet healthcare needs and more difficulty accessing healthcare.

General health surveys in Norway do not include people with intellectual disabilities, and studies of health indicators in this group are largely lacking. Further, the unique organization of services for this group in Norway calls for specific research efforts. This project will use multinational health indicators for youths and adults with IDs in a biopsychosocial context in attempt to identify unmet health care needs to improve services. The project will focus on mental health and challenging behavior and how the related healthcare needs are met. We will also look at the relationship between mental health, behavioral problems and workforce employment amongst people with intellectual disabilities.

Detailed Description

Intellectual disability (ID) is a diagnosis characterized by significant limitations both in intellectual functioning and in adaptive behavior as expressed in conceptual, social and practical adaptive skills. The disability originates before age 18 years. The prevalence of mental ill-health among adults with intellectual disabilities is higher than the general population. Individuals with ID use psychotropic medication extensively, but studies indicate that less than one out of three who use psychotropic drugs have a psychiatric diagnosis. The drugs are usually prescribed by a regular general practitioner. People with IDs will often require health- and social services throughout their lifetimes. Studies report worse mental and physical health among people with IDs compared to the general population, in addition to more unmet healthcare needs and more difficulty accessing healthcare.

General health surveys in Norway do not include people with intellectual disabilities, and studies of health indicators in this group are largely lacking. Further, the unique organization of services for this group in Norway calls for specific research efforts. This project will use multinational health indicators for youths and adults with IDs in a biopsychosocial context in attempt to identify unmet health care needs to improve services. The project will focus on mental health and challenging behavior and how the related healthcare needs are met. We will also look at the relationship between mental health, behavioral problems and workforce employment amongst people with intellectual disabilities.

The following articles will be published as part of this project:
  1. "The relationship between symptoms of mental health problems, diagnoses and medication in adults with intellectual disabilities"

  2. "The contact between individuals with intellectual disabilities with mental health problems, and mental health professionals: characteristics of the patients and the professionals.

  3. "Mental health, behavioral problems and workforce employment amongst people with intellectual disabilities".

Study Design

Study Type:
Observational [Patient Registry]
Actual Enrollment :
214 participants
Observational Model:
Ecologic or Community
Time Perspective:
Cross-Sectional
Official Title:
Mental Health and Healthcare in Adults With Intellectual Disabilities
Actual Study Start Date :
Oct 1, 2017
Actual Primary Completion Date :
Dec 1, 2019
Actual Study Completion Date :
Dec 1, 2019

Outcome Measures

Primary Outcome Measures

  1. Health indicators in a Norwegian population of youths and adults with intellectual disabilities. [Baseline]

    Health indicators as measured by The POMONA Checklist of Health Indicators (P15). The health indicators include measures of socio-demographics, Health status, Health determinants and Health systems.Physical Activity is defined as a Health determinant in this study in accordance With the POMONA Health indicator classification.

Secondary Outcome Measures

  1. The Aberrant Behaviour Checklist-Community (ABC-C) [Baseline]

    The Aberrant Behaviour Checklist-Community (ABC-C) is a rating scale with 58 items for the assessment of behavioural problems in people with intellectual disabilities. The items are grouped into five subscales: (I) Irritability (15 items), (II) Social Withdrawal (16 items), (III) Stereotypic Behaviour (7 items), (IV) Hyperactivity/Non-compliance (16 items) and (V) Inappropriate Speech (4 items).

  2. Moss Psychiatric Assessement Schedules- Checklist (MPAS- Check) [Baseline]

    The checklist is a screening instrument specifically designed to help staff recognize mental health problems in the people with intellectual disability for whom they care, and to make informed referral decisions. The instrument consists of a life-events checklist and 29 symptom items scored on a four-point scale

Eligibility Criteria

Criteria

Ages Eligible for Study:
16 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Clinical diagnosis of intellectual disability

  • Age 16 or older and providing consent to participate.

Exclusion Criteria:
  • Age 15 or younger.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Norwegian University of Science and Technology Trondheim Norway 7023

Sponsors and Collaborators

  • Norwegian University of Science and Technology
  • The Dam Foundation
  • University of Tromso
  • University Hospital of North Norway
  • The Norwegian Association for Persons with Developmental Disabilities

Investigators

  • Study Chair: Erik Søndenaa, PhD, Department of Mental Health, Faculty of Medicine and Health Sciences, NTNU.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Norwegian University of Science and Technology
ClinicalTrials.gov Identifier:
NCT05703503
Other Study ID Numbers:
  • 493747
  • 2022/FO387091
First Posted:
Jan 30, 2023
Last Update Posted:
Feb 3, 2023
Last Verified:
Feb 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Norwegian University of Science and Technology
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 3, 2023